<DOC>
	<DOCNO>NCT02868086</DOCNO>
	<brief_summary>The treatment neovascular age-related macular degeneration ( ARMD ) major issue public health . The therapeutic arsenal widely grow throughout year emergence intra-vitreous anti-angiogenic treatment , different surveillance protocol . The `` PRN '' surveillance ( pro nata : on-demand treatment monthly follow-up ) allow faster re-injection case neovascular relapse order maintain best visual acuity . This therapeutic protocol guide sub-retinal neovascular sign activity . The monitoring do common practice via OCT B scan show indirect sign neovascular activity ( exudation sign ) . OCT retinal imaging recently enrich new program allow visualization sub-retinal neovessels without use dye ( OCT angiography ) . The OCT angiography automatically do program use standard OCT section . During monitor patient use OCT A , sign renew neovascular activity represent `` arterialization '' development arteriole network neovessel reappearance hyper reflective flow neovascular regressive phase . Indeed , visualization neovessels monitor Angio-OCT may lead therapeutical modification ( anticipation injection ) . Knowing injection time-table ARMD patient treat anti-angiogenics determine sub-retinal neovascular sign activity . This activity evaluate routine clinical practice specific sign , observable OCT B scan . The hypothesis study search activity sin Angio-OCT , new technic image analysis perform OCT , may modify injection time-table , impact patient 's visual acuity .</brief_summary>
	<brief_title>The Impact Two Strategies Monitoring Exudative ARMD Visual Acuity ( OCT B Scan OCT Angiography )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Adult patient â‰¥ 50 year old exudative ARMD , treat intravitreous antiangiogenics follow PRN protocol ( pro nata ) Absence atrophy central pigment epithelium Visual acuity 20/63 20/200 Exclusion Criteria Opposition participate research Persons enjoy legal protection measure Lack affiliation social security universal health coverage Pregnant lactate Another cause Choroidal neovascularization Unbalanced glaucoma Eye surgery le 3 month study eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Age-related macular degeneration</keyword>
	<keyword>Optical coherence tomography angiography</keyword>
</DOC>